Ferric Derisomaltose Injection

DRUG3 trials

Sponsors

Alberta Health Services, Calgary, Hallym University Medical Center, Sichuan Huiyu Pharmaceutical Co., Ltd

Conditions

AnemiaAnemia, Iron DeficiencyGynecologic CancerIron Deficiency AnemiaSurgery

Phase 1

A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions

RecruitingNCT07790562

Sichuan Huiyu Pharmaceutical Co., LtdIron Deficiency Anemia

Start: 2026-07-23End: 2026-11-01Target: 88Updated: 2026-08-27

Phase 3

Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS

Alberta Health Services, CalgaryAnemia, Iron Deficiency, Gynecologic Cancer, Surgery

Start: 2022-09-30End: 2023-12-31Target: 82Updated: 2022-07-20

High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia

Hallym University Medical CenterAnemia

Start: 2023-03-01End: 2025-12-31Target: 312Updated: 2023-03-15